Antibodies News and Research

RSS

Vaccines targeting chronic diseases show promise in combatting age-related conditions

Vaccine-based therapeutics for age-related disorders.

17 Apr 2024

Research unveils bispecific antibodies for B-cell lymphoma treatment

A new research paper was published in Oncotarget's Volume 15 on April 12, 2024, entitled, "Novel therapeutic bispecific antibodies for B-cell lymphoma targeting IgM and other antigens on the B-cell surface."

16 Apr 2024

Study shows potential for universal flu vaccine with broad antibody response

Study discusses the potential of universal influenza vaccines, emphasizing the importance of antibody breadth and Fc receptor (FcR) effector functions in protecting against various influenza strains, including those with pandemic potential.

15 Apr 2024

Novel vaccine approach effective against all virus strains

Scientists at UC Riverside have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely even by babies or the immunocompromised.

15 Apr 2024

Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity

Researchers identified how SARS-CoV-2 targets and manipulates specific lung cells, using innovative techniques to trace the virus's impact on the cells' gene expression, revealing insights into early COVID-19 pathogenesis.

14 Apr 2024

Proteasomes: Expanding roles beyond cellular waste management

The typical job of the proteasome, the garbage disposal of the cell, is to grind down proteins into smaller bits and recycle some of those bits and parts.

13 Apr 2024

New murine model sheds light on anti-MDA5 antibody-positive dermatomyositis

Some diseases involve autoimmune reactions, when the body begins to attack its own cells and proteins.

13 Apr 2024

Alarmin molecule identified as therapeutic target for allergic respiratory diseases

One of the molecules responsible for triggering the inflammation that causes allergic respiratory diseases, such as asthma and allergic rhinitis, has just been discovered by scientists from the CNRS, Inserm and the Université Toulouse III – Paul Sabatier.

12 Apr 2024

Study reveals unexpected vulnerability of lung immune cells to SARS-CoV-2

The lung-cell type that's most susceptible to infection by SARS-CoV-2, the virus that causes COVID-19, is not the one previously assumed to be most vulnerable.

10 Apr 2024

Sugar abnormalities in the blood may promote biological aging and inflammation in HIV patients

The Wistar Institute's associate professor Mohamed Abdel-Mohsen, Ph.D., along with his team and collaborators, has identified sugar abnormalities in the blood that may promote biological aging and inflammation in people living with HIV (PLWH).

10 Apr 2024

Maternal influences on food allergy prevention: A closer look at diet and environment

Review assesses how maternal diet and environmental factors during pregnancy influence the prevention of food allergies in offspring, underlining the importance of a balanced diet and questioning the efficacy of allergen avoidance.

9 Apr 2024

Researchers find new clues to understanding the progression of primary membranous nephropathy

No therapies currently exist that can halt the progression of chronic kidney disease in children or restore the ability of kidney cells to filter blood.

9 Apr 2024

Research identifies how leukemia develops resistance to first line treatments

Relapses in a common form of leukemia may be preventable following new research which has identified how the cancer develops resistance to first line treatments.

9 Apr 2024

Pioneering vaccine strategy promises to outmaneuver antimicrobial resistance

Study introduces Reverse Vaccine Development as a strategic approach to identify correlates of protection early in vaccine development against antimicrobial-resistant pathogens, aiming to mitigate risks such as significant phase-III clinical trial failures.

7 Apr 2024

Gold nanoparticle adorned polymers boost infectious disease testing

By harnessing the power of composite polymer particles adorned with gold nanoparticles, a group of researchers have delivered a more accurate means of testing for infectious diseases.

5 Apr 2024

Therapeutic potential of CD20 x CD3 bispecific antibodies

On Monday, March 25th, 2024, the U.S. FDA declined approval for Regeneron’s Odronextamab for two forms of lymphoma due to concerns over the progress of ongoing confirmatory trials.

From Sino Biological Inc. 5 Apr 2024

Muscles in microgravity: Spaceflight duration impacts muscle protein stress markers

Study explores the differential effects of short and long-duration space missions on muscle protein nitrosylation in astronauts, indicating adaptations and potential impairments in muscle function due to microgravity, and highlights the role of inflight exercise in mitigating some negative effects on muscle health.

3 Apr 2024

Innovative approach to disrupt misfolding of tau proteins in neurodegenerative diseases

A spectrum of neurodegenerative diseases, including frontotemporal dementia (FTD), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are due to the accumulation of abnormal, misfolded tau proteins in the brain.

3 Apr 2024

Innovative molecular biology technique used to identify targets for Schistosoma mansoni vaccine candidates

Researchers in Brazil have used an innovative technique in molecular biology to identify targets for candidate vaccines against Schistosoma mansoni, the parasite that causes schistosomiasis.

2 Apr 2024

Research suggests booster doses may be necessary for monkeypox immunity

New research to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows that even in men who receives two doses of mpox vaccine intradermally, their level of antibodies to the virus falls to low or zero within the first few months if they have not received a previous smallpox vaccine.

1 Apr 2024

Antibodies News and Research

Vaccines targeting chronic diseases show promise in combatting age-related conditions

Research unveils bispecific antibodies for B-cell lymphoma treatment

Study shows potential for universal flu vaccine with broad antibody response

Novel vaccine approach effective against all virus strains

Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity

Proteasomes: Expanding roles beyond cellular waste management

New murine model sheds light on anti-MDA5 antibody-positive dermatomyositis

Alarmin molecule identified as therapeutic target for allergic respiratory diseases

Study reveals unexpected vulnerability of lung immune cells to SARS-CoV-2

Sugar abnormalities in the blood may promote biological aging and inflammation in HIV patients

Maternal influences on food allergy prevention: A closer look at diet and environment

Researchers find new clues to understanding the progression of primary membranous nephropathy

Research identifies how leukemia develops resistance to first line treatments

Pioneering vaccine strategy promises to outmaneuver antimicrobial resistance

Gold nanoparticle adorned polymers boost infectious disease testing

Therapeutic potential of CD20 x CD3 bispecific antibodies

Muscles in microgravity: Spaceflight duration impacts muscle protein stress markers

Innovative approach to disrupt misfolding of tau proteins in neurodegenerative diseases

Innovative molecular biology technique used to identify targets for Schistosoma mansoni vaccine candidates

Research suggests booster doses may be necessary for monkeypox immunity

Antibodies eBook

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Latest Life Science News